Literatur
nach Informationen der Boehringer Ingelheim Pharma GmbH & Co. KG
Author information
Consortia
Rights and permissions
About this article
Cite this article
Springer Medizin-Verlag. Positives CHMP-Votum für Nintedanib. best practice onkologie 9, 33 (2014). https://doi.org/10.1007/s11654-014-0569-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11654-014-0569-z